KYTX — Kyverna Therapeutics
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 127 家机构在其最新 13F 申报中持有 KYTX(Kyverna Therapeutics),合计申报市值 $349.99M,对应 40.47M 股。按股数计算较上季度增持 4.6%(+1.68M 股),申报市值环比上升 9.3%。持仓集中度较高:前五大持有人占申报市值的 43.8%,前十大的集中度为 62.0%。
与上一季度相比,34 家新建仓位、38 家加仓、29 家减仓、24 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
Kyverna Therapeutics(KYTX)的主要机构持有人包括 GordonMD Global Investments LP、JENNISON ASSOCIATES LLC、GILEAD SCIENCES, INC.,按 13F 申报市值在本页 255 家持有人中排名居前。
KYTX 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 83 | 21.37M | $145.18M | +12.5% |
| Q2 2026 | 127 | 40.47M | $349.99M | +4.6% |
| Q1 2026 | 117 | 37.71M | $312.05M | +5.9% |
| Q4 2025 | 106 | 36.53M | $326.76M | +13.4% |
| Q3 2025 | 78 | 20.03M | $111.27M | -4.1% |
| Q2 2025 | 81 | 20.74M | $58.22M | +6.4% |
| Q1 2025 | 89 | 21.31M | $40.19M | -15.2% |
| Q4 2024 | 89 | 25.89M | $94.77M | +1.4% |
表内 8 个季度中,机构持股合计减少 17%(Q4 2024 → Q3 2026);单季变动最大的是 Q1 2025(-15.2%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.13M | $28.06M | 1.92% | 持有 | |
| 3.65M | $24.82M | 2.50% | 增持 | |
| 3.24M | $22.02M | 0.00% | 增持 | |
| 2.01M | $13.68M | 0.00% | 增持 | |
| 1.20M | $8.18M | 0.00% | 增持 | |
| 1.05M | $7.17M | 0.00% | 持有 | |
| 700.60K | $4.76M | 2.53% | 减持 | |
| 599.28K | $4.08M | 0.00% | 增持 | |
| 552.25K | $3.76M | 0.00% | 减持 | |
| 538.38K | $3.66M | 0.00% | 增持 | |
| 360.49K | $2.45M | 0.00% | 增持 | |
| 327.82K | $2.23M | 0.00% | 减持 | |
| 278.57K | $1.89M | 0.00% | 增持 | |
| 276.02K | $1.88M | 0.00% | 减持 | |
| 259.51K | $1.76M | 0.00% | 持有 | |
| 239.94K | $1.63M | 0.00% | 增持 | |
| 182.60K | $1.24M | 0.02% | 持有 | |
| 145.68K | $996.47K | 0.00% | 持有 | |
| 139.92K | $951.47K | 0.00% | 持有 | |
| 136.13K | $925.71K | 0.00% | 增持 | |
| 128.99K | $877.15K | 0.00% | 新进 | |
| 104.45K | $710.27K | 0.00% | 增持 | |
| 100.70K | $684.76K | 0.00% | 增持 | |
| 90.00K | $612.00K | 0.44% | 增持 | |
| 73.28K | $498.28K | 0.00% | 新进 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.13M | $24.76M | 1.38% | 持有 | |
| 3.37M | $20.21M | 1.34% | 持有 | |
| 1.51M | $9.07M | 0.00% | 减持 | |
| 1.32M | $7.94M | 0.00% | 增持 | |
| 989.05K | $5.93M | 0.37% | 持有 | |
| 677.59K | $4.07M | 0.00% | 减持 | |
| 614.48K | $3.69M | 0.49% | 持有 | |
| 586.91K | $3.52M | 0.65% | 持有 | |
| 551.63K | $3.31M | 0.01% | 增持 | |
| 551.63K | $3.31M | 0.00% | 增持 | |
| 482.05K | $2.89M | 0.00% | 减持 | |
| 421.92K | $2.53M | 0.38% | 持有 | |
| 318.76K | $1.91M | 1.71% | 减持 | |
| 278.33K | $1.67M | 0.00% | 减持 | |
| 252.21K | $1.51M | 0.01% | 新进 | |
| 174.90K | $1.05M | 0.02% | 增持 | |
| 174.20K | $1.05M | 0.00% | 减持 | |
| 164.80K | $988.78K | 0.00% | 减持 | |
| 164.61K | $987.68K | 0.00% | 增持 | |
| 157.42K | $944.53K | 0.00% | 增持 | |
| 147.71K | $886.27K | 0.00% | 新进 | |
| 132.45K | $794.71K | 0.00% | 增持 | |
| 125.58K | $753.47K | 0.00% | 增持 | |
| 125.58K | $753.47K | 0.00% | 增持 | |
| 103.81K | $622.85K | 0.00% | 减持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.13M | $12.67M | 0.99% | 持有 | |
| 3.37M | $10.34M | 1.29% | 持有 | |
| 1.83M | $5.62M | 0.00% | 增持 | |
| 1.31M | $4.03M | 0.00% | 增持 | |
| 989.05K | $3.04M | 0.13% | 持有 | |
| 695.03K | $2.13M | 0.00% | 持有 | |
| 614.48K | $1.89M | 0.19% | 持有 | |
| 586.91K | $1.80M | 0.38% | 持有 | |
| 533.47K | $1.64M | 0.00% | 减持 | |
| 452.56K | $1.39M | 0.00% | 增持 | |
| 452.56K | $1.39M | 0.00% | 增持 | |
| 421.92K | $1.30M | 0.26% | 增持 | |
| 396.76K | $1.22M | 1.22% | 持有 | |
| 287.60K | $883.11K | 0.00% | 减持 | |
| 252.20K | $774.24K | 0.00% | 增持 | |
| 202.04K | $620.26K | 0.00% | 增持 | |
| 142.54K | $437.60K | 0.55% | 减持 | |
| 136.38K | $418.68K | 0.00% | 增持 | |
| 122.42K | $375.82K | 0.00% | 减持 | |
| 120.58K | $370.19K | 0.00% | 减持 | |
| 118.61K | $364.12K | 0.00% | 减持 | |
| 118.61K | $364.12K | 0.00% | 减持 | |
| 118.30K | $363.17K | 0.00% | 增持 | |
| 100.16K | $307.49K | 0.00% | 增持 | |
| 100.16K | $307.49K | 0.00% | 增持 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 1.05M 股 · $9.35M
- Sixth Street Partners Management Company, L.P. 319.67K 股 · $2.85M
- VANGUARD PORTFOLIO MANAGEMENT LLC 282.19K 股 · $2.51M
- Nuveen, LLC 233.74K 股 · $2.08M
- Wellington Management Group 117.44K 股 · $1.05M
- WELLINGTON MANAGEMENT GROUP LLP 117.44K 股 · $1.05M
- BNY Mellon 100.28K 股 · $893.50K
- RHUMBLINE ADVISERS 50.19K 股 · $447.17K
- SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 45.36K 股 · $404.16K
- Mitsubishi UFJ Asset Management Co., Ltd. 25.74K 股 · $229.35K
- MetLife Investment Management, LLC 25.62K 股 · $228.32K
- Spark Investment Management LLC 25.10K 股 · $223.64K
完全清仓(较上季)
- Marshall Wace 卖出 605.51K 股 · $5.23M
- Point72 Asset Management 卖出 222.93K 股 · $1.92M
- STATE STREET CORP 卖出 138.30K 股 · $1.19M
- 683 Capital Management, LLC 卖出 85.00K 股 · $733.55K
- Hudson Bay Capital Management LP 卖出 71.06K 股 · $613.24K
- Brevan Howard Capital Management LP 卖出 63.52K 股 · $548.14K
- VOYA INVESTMENT MANAGEMENT LLC 卖出 44.05K 股 · $380.11K
- Peapod Lane Capital LLC 卖出 40.40K 股 · $336.47K
- Quadrature Capital Ltd 卖出 38.41K 股 · $331.49K
- MANGROVE PARTNERS IM, LLC 卖出 27.01K 股 · $233.13K
- Jefferies Financial Group Inc. 卖出 23.92K 股 · $206.43K
- ADAR1 Capital Management, LLC 卖出 22.43K 股 · $193.55K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 4.13M | 4.13M | 4.13M | 4.13M | 4.13M | 4.13M | 4.13M | 4.13M | — | — | — |
| AIGH Capital Management LLC | 3.65M | 2.80M | 2.00M | 1.50M | — | — | — | — | — | — | — |
| BlackRock Inc | 3.24M | 3.13M | 877.08K | 544.54K | 482.05K | 533.47K | 1.68M | 1.67M | 1.52M | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.01M | 1.90M | 1.78M | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 1.20M | — | 138.30K | 91.30K | 91.30K | 91.30K | 374.58K | 379.89K | 326.19K | 315.95K | 50.40K |
| Geode Capital Management | 1.05M | 1.05M | 423.83K | 266.40K | 278.33K | 287.60K | 563.97K | 539.68K | 443.31K | 372.60K | 172.24K |
| Propel Bio Management, LLC | 700.60K | 883.20K | 644.42K | 666.67K | — | — | — | — | — | — | — |
| UBS Group AG | 599.28K | 365.57K | 449.75K | 202.19K | 157.42K | 98.16K | 177.67K | 203.40K | 8.20K | 9.64K | 24.90K |
| Morgan Stanley | 552.25K | 982.31K | 977.29K | 1.00M | 174.20K | 202.04K | 134.91K | 200.59K | 119.79K | 119.28K | 39.93K |
| Fidelity Management & Research (FMR) | 538.38K | 96.05K | 6.81K | 6.98K | 7.92K | 8.18K | 2.39K | 1.61K | 6.69K | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 360.49K | 282.19K | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | 327.82K | 333.90K | 367.49K | 177.90K | 164.61K | 122.42K | 124.96K | 44.70K | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 278.57K | 78.42K | 78.42K | 78.41K | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 276.02K | 310.63K | 412.03K | 252.15K | 34.02K | 4.43K | 46.38K | 44.98K | 27.20K | 1.20K | — |
| VANGUARD FIDUCIARY TRUST CO | 259.51K | 259.67K | 224.58K | — | — | — | — | — | — | — | — |
| Nuveen, LLC | 239.94K | 233.74K | — | — | — | — | 47.51K | — | — | — | — |
| Simplify Asset Management Inc. | 182.60K | 182.60K | 173.11K | 192.34K | — | — | — | — | — | — | — |
| TD ASSET MANAGEMENT INC | 145.68K | 145.68K | 169.08K | 222.80K | 164.80K | 252.20K | 90.24K | 90.24K | 90.24K | 90.24K | — |
| STIFEL FINANCIAL CORP | 139.92K | 139.97K | 130.52K | 125.79K | 38.82K | 38.97K | 39.16K | 39.34K | — | — | — |
| BARCLAYS PLC | 136.13K | 117.84K | 136.38K | 164.67K | 76.19K | 50.39K | 81.39K | 89.59K | 70.17K | 57.75K | 43.09K |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold KYTX?
As of 2026-Q2, 127 institutional funds reported holding KYTX (Kyverna Therapeutics) in SEC 13F filings, with a combined reported value of $349.99M.
How many shares of KYTX do institutions own?
13F filers reported 40.47M shares of KYTX, worth $349.99M in aggregate at the end of 2026-Q2.
Is institutional ownership of KYTX rising or falling?
Share counts moved +4.6% versus the prior quarter — accumulation.
Who are the top institutional holders of KYTX?
The largest 13F holders are GordonMD Global Investments LP, JENNISON ASSOCIATES LLC, GILEAD SCIENCES, INC., Bain Capital Life Sciences Investors, LLC, AIGH Capital Management LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of Kyverna Therapeutics?
The major shareholders of Kyverna Therapeutics (KYTX) by reported 13F value are GordonMD Global Investments LP, JENNISON ASSOCIATES LLC, GILEAD SCIENCES, INC., Bain Capital Life Sciences Investors, LLC, AIGH Capital Management LLC, among 255 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.